FIELDBOSS Wins the 2025 Business Impact of the Year Award from Resco for Excellence in Field Service Software
FIELDBOSS, the leading field service management software platform for HVAC and elevator contractors, is proud to announce it has been awarded the 2025 Business Impact of the Year Award from Resco.
Aventura, Florida--(Newsfile Corp. - June 12, 2025) - FIELDBOSS, the award-winning field service management software platform for HVAC and elevator contractors, is proud to announce it has been given the 2025 Business Impact of the Year Award from Resco.
The honour recognizes FIELDBOSS for delivering the most impactful vertical solution and generating the highest revenue using Resco technology at its core.
FIELDBOSS Wins the 2025 Business Impact of the Year Award from Resco for Excellence in Field Service Software
To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8814/255334_fdb4e26a7467db35_002full.jpg
Presented at Resco Next 2025 in Valencia, Spain, this marks the fourth Resco award for FIELDBOSS and underscores the company's commitment to building vertical-specific software that solves real field service problems.
"Our mobile app isn't just a feature – it's a mission-critical tool for contractors in the field," said Jonathan Taub, President of FIELDBOSS. "Winning Business Impact of the Year is especially meaningful because it acknowledges the tangible outcomes our customers experience every day—fewer truck rolls, faster inspections, better service. It's a reflection of the hard work, shared passion, and close collaboration between the FIELDBOSS and Resco teams."
The Resco mobile platform powers every FIELDBOSS implementation. With over 95% of HVAC and elevator customers relying on the mobile app daily, FIELDBOSS continues to push the boundaries of what's possible in mobile field service automation. In 2024 alone, FIELDBOSS customers completed over 3.5 million field reports through the Resco-powered app – an all-time high. Customer sentiment remains strong, with satisfaction scores for the FIELDBOSS mobile experience averaging 4.7 out of 5 across post-implementation surveys.
A key driver of this success has been the ongoing innovation behind the FIELDBOSS mobile app. In its latest Version 6 release, FIELDBOSS delivered major updates to inspection modules, data capture, and offline capabilities—empowering technicians to work more efficiently, even in remote or low-connectivity environments.
Corey Barss, Director of Consulting at FIELDBOSS, added:
"Our commitment to field teams goes beyond just building software – we're constantly asking how we can make work easier, faster, and more accessible, no matter where the job takes them. Version 6 was a leap forward in mobile functionality, and we're not slowing down. We stay tightly aligned with Microsoft's Dynamics 365 roadmap, including upcoming AI capabilities, to ensure that our customers always have the latest, smartest tools in their hands."
FIELDBOSS has long embraced the role of early adopter and trusted advisor within the Resco ecosystem. The product team regularly tests and implements the newest Resco features before public release, providing field-tested feedback that helps guide platform innovation. This collaborative spirit has made FIELDBOSS a model partner for Resco's vision of mobile-first field service.
"Receiving this award at Masia Aldamar, surrounded by craftsmanship and tradition, was especially moving," added Taub. "Winemakers pour their hearts into their work, and so do we. This is the result of many hands, much effort, and a relentless focus on quality."
This is FIELDBOSS' fourth Resco award, having previously earned Breakthrough Partner of the Year (2020), Business Impact of the Year (2021), and Partner of the Year (2023). The 2025 Business Impact win affirms the company's long-term growth, deep field service expertise, and sustained product excellence.
About FIELDBOSS
FIELDBOSS is purpose-built field service management software for HVAC and elevator contractors. It integrates seamlessly with Microsoft Dynamics 365 and leverages Resco mobile technology to help field teams operate more efficiently, reduce operational risk, and better serve customers. With decades of industry expertise and a relentless focus on field operations, FIELDBOSS empowers contractors to run smarter, more profitable businesses.
About Resco
Resco is a global leader in cross-platform enterprise mobility solutions. Founded in 1999, Resco serves over 800 enterprise customers and more than 160,000 licensed users worldwide. Its mobile platform enables field teams to collect data, streamline workflows, and digitize business operations-anytime, anywhere.
Contact Info:Name: Corry GreenbaumEmail: corry.greenbaum@rimrock.comOrganization: FIELDBOSSAddress: 2875 NE 191st St. STE 500 Aventura, FL 33180Phone: 647-905-6888Website: https://www.fieldboss.com/
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/255334
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
2 hours ago
- Associated Press
WNP Launches All-in-One Hyaluronic Acid Skincare Set, Pioneering a "3-Step Scientific Skincare Method"
Culver City, California--(Newsfile Corp. - June 22, 2025) - Skincare brand WNP officially launched the 'All-in-One Hyaluronic Acid Skincare Set' on its website, introducing its original 'Three-Step Scientific Skincare Method.' The set integrates five key skincare steps - cleansing, hydration, repair, brightening, and early-stage anti-aging - into a comprehensive skincare system based on four core innovations: nano-delivery, HTAC thermal water dynamics, 4D hyaluronic acid, and microencapsulation technology. This set offers a streamlined solution for everyday skincare needs. [ This image cannot be displayed. Please visit the source: ] From cleanse to anti-aging - the complete, science-backed routine for hydrated, balanced, glowing skin. To view an enhanced version of this graphic, please visit: Four Key Innovations Nano-Liposome Delivery WNP utilizes nano-liposome technology to reduce Ceramide NP particle size to below 100 nm, enabling targeted delivery to the basal layer of the stratum corneum. Lab tests show it helps fill intercellular lipid gaps and reduce transepidermal water loss, offering industry-leading repair benefits for sensitive and barrier-damaged skin. HTAC Thermal Decomposition Water Dynamics WNP's toner features Italian patented HTAC technology, which protects red algae and recombinant collagen activity. Tests show it boosts natural hyaluronic acid production by 124% and cellular mitochondrial activity by 229%. 4D Hyaluronic Acid Multi-Layer Hydration Based on Bloomage Biotech's 4D hyaluronic acid formulation, four molecular weights of hyaluronic acid penetrate from the epidermis to the dermis. Combined with a water-in-oil lamellar emulsion structure, this provides deep, lasting hydration. Microencapsulated Time-Release Salicylic Acid Salicylic acid is microencapsulated for sustained release of active ingredients, delivering gentle exfoliation while minimizing irritation. Ideal for daily use on sensitive or combination-oily skin. Five Steps, One Streamlined Routine Gentle Cleansing: A non-soap amino acid cleanser with pH 5.5-6, refined through 45℃ natural crystallization to remove excess emulsifiers. Fine foam gently purifies without residue. Soothing & Hydration: A serum-texture toner that forms a water film on contact. Functions as both mist and toner for instant moisture. Targeted Hydration: 3% Hyaluronic Acid Capsules, a TikTok bestseller, delivers precise hydration without pilling. Brighten & Even: A matrix of niacinamide, SymWhite®377, and vitamin C derivatives to block melanin transfer and fade oxidized spots. Early Anti-Aging: Patented recombinant collagen, triple peptides, and multiple ceramides to rebuild elasticity and visibly firm skin within 28 days. Brand Vision 'With this launch, WNP merges cutting-edge nano-delivery with a multi-dimensional hyaluronic hydration system to redefine what 'minimalist skincare' can mean,' said WNP's Chief Product Spokesperson-Dr. Emily. 'We believe skincare is shifting from ingredient stacking to true tech-enabled performance-and this launch is the clearest expression of that evolution.' About WNP WNP (Wake Nature Perfection) is a science-driven skincare brand based in Asia, rooted in the philosophy of precision skincare. It integrates top-tier dermatological research with global innovations in active ingredients. As an industry innovator, WNP has introduced multiple 'first-of-its-kind' technologies in both domestic and international markets, committed to delivering safe, effective, and targeted skincare solutions. For more information, please visit Source: WNP Contact: Matt Department: Brand Team Email: [email protected] To view the source version of this press release, please visit
Yahoo
5 hours ago
- Yahoo
WNP Launches All-in-One Hyaluronic Acid Skincare Set, Pioneering a "3-Step Scientific Skincare Method"
Culver City, California--(Newsfile Corp. - June 22, 2025) - Skincare brand WNP officially launched the "All-in-One Hyaluronic Acid Skincare Set" on its website, introducing its original "Three-Step Scientific Skincare Method." The set integrates five key skincare steps - cleansing, hydration, repair, brightening, and early-stage anti-aging - into a comprehensive skincare system based on four core innovations: nano-delivery, HTAC thermal water dynamics, 4D hyaluronic acid, and microencapsulation technology. This set offers a streamlined solution for everyday skincare needs. From cleanse to anti-aging - the complete, science-backed routine for hydrated, balanced, glowing skin. To view an enhanced version of this graphic, please visit: Four Key Innovations Nano-Liposome Delivery WNP utilizes nano-liposome technology to reduce Ceramide NP particle size to below 100 nm, enabling targeted delivery to the basal layer of the stratum corneum. Lab tests show it helps fill intercellular lipid gaps and reduce transepidermal water loss, offering industry-leading repair benefits for sensitive and barrier-damaged skin. HTAC Thermal Decomposition Water Dynamics WNP's toner features Italian patented HTAC technology, which protects red algae and recombinant collagen activity. Tests show it boosts natural hyaluronic acid production by 124% and cellular mitochondrial activity by 229%. 4D Hyaluronic Acid Multi-Layer Hydration Based on Bloomage Biotech's 4D hyaluronic acid formulation, four molecular weights of hyaluronic acid penetrate from the epidermis to the dermis. Combined with a water-in-oil lamellar emulsion structure, this provides deep, lasting hydration. Microencapsulated Time-Release Salicylic Acid Salicylic acid is microencapsulated for sustained release of active ingredients, delivering gentle exfoliation while minimizing irritation. Ideal for daily use on sensitive or combination-oily skin. Five Steps, One Streamlined Routine Gentle Cleansing: A non-soap amino acid cleanser with pH 5.5-6, refined through 45℃ natural crystallization to remove excess emulsifiers. Fine foam gently purifies without residue. Soothing & Hydration: A serum-texture toner that forms a water film on contact. Functions as both mist and toner for instant moisture. Targeted Hydration: 3% Hyaluronic Acid Capsules, a TikTok bestseller, delivers precise hydration without pilling. Brighten & Even: A matrix of niacinamide, SymWhite®377, and vitamin C derivatives to block melanin transfer and fade oxidized spots. Early Anti-Aging: Patented recombinant collagen, triple peptides, and multiple ceramides to rebuild elasticity and visibly firm skin within 28 days. Brand Vision "With this launch, WNP merges cutting-edge nano-delivery with a multi-dimensional hyaluronic hydration system to redefine what 'minimalist skincare' can mean," said WNP's Chief Product Spokesperson-Dr. Emily. "We believe skincare is shifting from ingredient stacking to true tech-enabled performance-and this launch is the clearest expression of that evolution." About WNP WNP (Wake Nature Perfection) is a science-driven skincare brand based in Asia, rooted in the philosophy of precision skincare. It integrates top-tier dermatological research with global innovations in active ingredients. As an industry innovator, WNP has introduced multiple "first-of-its-kind" technologies in both domestic and international markets, committed to delivering safe, effective, and targeted skincare solutions. For more information, please visit Source: WNPContact: MattDepartment: Brand TeamEmail: matt@ To view the source version of this press release, please visit
Yahoo
2 days ago
- Yahoo
LevelJump Announces 2024 Financial Results
Toronto, Ontario--(Newsfile Corp. - June 20, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the year ended December 31, 2024. Financial and Operational Highlights Revenues were $17.7 million in 2024 compared to $12.6 million in revenues for 2023, a year over year revenue increase of 41%. Canadian Teleradiology Services, Inc., the Company's 100% owned subsidiary had EBITDA for 2024 of $3.35 million. 2024 Financial Results for fourth quarter and year Revenues of $4.8 million in Q4 2024 and $17.7 million for the year 2024 with a net profit of $1.95 million for Q4 2024 and a net profit of $1.2 million for the year 2024. EBITDA of $395,936 for Q4 2024 and $1,545,298 for the year 2024. Subsequent Events Subsequent to the year end, the Company entered an agreement to acquire two additional diagnostic imaging outpatient clinic locations in Calgary, Alberta. The transaction is expected to close towards the end of July 2025. See the Company's news release dated June 13, 2025. Management Comments "2024 was a transformative year for our Company, marked by significant growth, particularly within our clinic operations," said Mitch Geisler, CEO. "Our year-over-year revenue increased by more than 40%, and we achieved strong EBITDA performance. We are now interpreting imaging scans for approximately 200,000 patients annually across all operations. Our focus remains on driving organic growth and advancing our long-term vision for continued expansion." Non-IFRS Financial Measures This news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-IFRS measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with IFRS. These financial measures are included because management uses this information to analyze operating performance and liquidity. For further details on the results, please refer to LevelJump's Management, Discussion and Analysis and Consolidated Financial Statements for the year ended December 31, 2024, which are available on the Company's website ( and under the Company's profile on SEDAR+ ( About LevelJump Healthcare LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve. ON BEHALF OF THE BOARD OF DIRECTORS OFLEVELJUMP HEALTHCARE CORP. Mitchell GeislerChief Executive Officerinfo@ CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable). Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
